Balance Sheet

Cash Flow Statement

Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Celularity (CELU) Deferred Taxes (2020 - 2021)

Celularity (CELU) has disclosed Deferred Taxes for 2 consecutive years, with $3000.0 as the latest value for Q4 2021.

For Q4 2021, Deferred Taxes rose 103.75% year-over-year to $3000.0; the TTM value through Dec 2021 reached -$1.4 million, up 84.05%, while the annual FY2022 figure was -$1000.0, 99.93% up from the prior year.
Deferred Taxes hit $3000.0 in Q4 2021 for Celularity, up from -$1.3 million in the prior quarter.
Across five years, Deferred Taxes topped out at $91930.0 in Q1 2020 and bottomed at -$8.4 million in Q3 2020.